Our Catapult Award program aims to accelerate the development of novel, innovative, less-toxic treatments for children with cancer.

The goal of the Catapult Award is to overcome barriers to pediatric cancer drug development by providing meaningful funding in order to advance the development of promising oncology research out of the lab and into clinical trials. Catapult Award funding ranges from $500,000 – $2.5 million.

Read the RFP for this award